OKYO Pharma Ltd
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +2,624.4% | +13,490.6% | -98.4% | +51,822.2% | +11.2% | -100.0% | +260,942.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -83.0% | -32.7% | +362.2% | +293.7% | +30.1% | -72.7% | -19.7% | |
| – | -39.8% | -65.4% | +57.9% | – | – | – | +454.3% | – | – | – | – | |
| – | -37.3% | -66.9% | +171.4% | +360.4% | -66.7% | +119.6% | +87.2% | +1.9% | +30.1% | -12.8% | -74.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -26.4% | -58.8% | -100.0% | – | – | -2.9% | -100.0% | – | +989.4% | -16.1% | -46.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -102.8% | – | – | -20,722,991.6% | – | – | – | – | – | -14,660.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -145.4% | – | – | -117.3% | – | – | – | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.